Michael Schatz, MD

home / authors / michael-schatz-md

Articles

February 17th 2018

Claims-Based Risk Model for First Severe COPD Exacerbation

Richard H. Stanford, PharmD, MS Arpita Nag, PhD, MBA, MS Douglas W. Mapel, MD Todd A. Lee, PhD Richard Rosiello, MD Michael Schatz, MD Francis Vekeman, MS Marjolaine Gauthier-Loiselle, PhD J.F. Philip Merrigan, PhD Mei Sheng Duh, ScD

A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.

March 9th 2010

Ratio of Controller to Total Asthma Medications: Determinants of the Measure

Michael S. Broder, MD Benjamin Gutierrez, PhD Eunice Chang, PhD David Meddis, PhD Michael Schatz, MD

The ratio of controller to total asthma medications can be calculated using 1 or 2 quarters of data; high versus low ratios differentiate patient characteristics.

April 15th 2008

Asthma-specific Quality of Life and Subsequent Asthma Emergency Hospital Care

Michael Schatz, MD Robert S. Zeiger, MD, PhD David Mosen, PhD William M. Vollmer, PhD

Asthma-specific quality of life and a history of acute episodes can be used together to identify risks of subsequent acute exacerbations.

December 1st 2007

Validity of the Asthma Control Test™ Completed at Home

Michael Schatz, MD David M. Mosen, PhD Mark Kosinski, MA William M. Vollmer, PhD David J. Magid, MD Elizabeth O'Connor, PhD Robert S. Zeiger, MD, PhD

August 1st 2006

Development and Validation of a Medication Intensity Scale Derived From Computerized Pharmacy Data That Predicts Emergency Hospital Utilization for Persistent Asthma